Fulcrum Therapeutics (FULC) Non-Current Assets (2019 - 2025)
Historic Non-Current Assets for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $9.0 million.
- Fulcrum Therapeutics' Non-Current Assets fell 2191.16% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.3 million, marking a year-over-year decrease of 2925.57%. This contributed to the annual value of $10.8 million for FY2024, which is 3033.24% down from last year.
- Per Fulcrum Therapeutics' latest filing, its Non-Current Assets stood at $9.0 million for Q3 2025, which was down 2191.16% from $9.5 million recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Non-Current Assets registered a high of $21.0 million during Q2 2022, and its lowest value of $9.0 million during Q3 2025.
- Over the past 5 years, Fulcrum Therapeutics' median Non-Current Assets value was $14.0 million (recorded in 2024), while the average stood at $13.9 million.
- As far as peak fluctuations go, Fulcrum Therapeutics' Non-Current Assets soared by 12401.79% in 2022, and later plummeted by 3224.77% in 2025.
- Quarter analysis of 5 years shows Fulcrum Therapeutics' Non-Current Assets stood at $9.0 million in 2021, then skyrocketed by 112.91% to $19.2 million in 2022, then decreased by 19.15% to $15.5 million in 2023, then tumbled by 30.33% to $10.8 million in 2024, then fell by 16.67% to $9.0 million in 2025.
- Its Non-Current Assets stands at $9.0 million for Q3 2025, versus $9.5 million for Q2 2025 and $10.1 million for Q1 2025.